Kornitzer Capital Management Inc. KS Has $3.39 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kornitzer Capital Management Inc. KS lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,626 shares of the medical equipment provider’s stock after buying an additional 62 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Intuitive Surgical were worth $3,392,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in ISRG. Indiana Trust & Investment Management CO increased its holdings in shares of Intuitive Surgical by 5.3% in the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock worth $222,000 after acquiring an additional 25 shares in the last quarter. Hoxton Planning & Management LLC increased its stake in Intuitive Surgical by 4.9% during the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after purchasing an additional 25 shares in the last quarter. First Affirmative Financial Network increased its stake in Intuitive Surgical by 2.7% during the 2nd quarter. First Affirmative Financial Network now owns 996 shares of the medical equipment provider’s stock worth $443,000 after purchasing an additional 26 shares in the last quarter. Advance Capital Management Inc. raised its holdings in Intuitive Surgical by 3.8% during the 1st quarter. Advance Capital Management Inc. now owns 740 shares of the medical equipment provider’s stock worth $295,000 after buying an additional 27 shares during the period. Finally, Perigon Wealth Management LLC lifted its stake in Intuitive Surgical by 0.5% in the first quarter. Perigon Wealth Management LLC now owns 5,363 shares of the medical equipment provider’s stock valued at $2,140,000 after buying an additional 27 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on ISRG. Barclays increased their price objective on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Morgan Stanley increased their target price on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a report on Monday, July 15th. The Goldman Sachs Group started coverage on Intuitive Surgical in a report on Thursday, May 30th. They issued a “buy” rating and a $500.00 price target on the stock. BTIG Research upped their price objective on Intuitive Surgical from $469.00 to $494.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. Finally, Robert W. Baird lifted their target price on Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $446.45.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at approximately $1,461,006.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 239 shares of the company’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $416.60, for a total transaction of $99,567.40. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,293,799.60. The disclosure for this sale can be found here. Insiders have sold 51,656 shares of company stock worth $24,700,644 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 1.0 %

NASDAQ ISRG opened at $476.69 on Friday. The firm has a market capitalization of $169.08 billion, a P/E ratio of 86.05, a price-to-earnings-growth ratio of 5.43 and a beta of 1.39. The firm’s fifty day moving average price is $458.20 and its two-hundred day moving average price is $417.34. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $493.97.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. During the same period in the prior year, the firm earned $1.18 EPS. Intuitive Surgical’s quarterly revenue was up 14.5% compared to the same quarter last year. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.